Sandu Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	699.35	671.92	672.81	653.49	655.01
Revenue	699.35	671.92	672.81	653.49	655.01
Revenue Growth (YoY)	4.08%	-0.13%	2.96%	-0.23%	11.48%
Cost of Revenue	315.72	342.36	346.4	332.83	378.31
Gross Profit	383.63	329.57	326.41	320.66	276.7
Selling, General & Admin	106.91	181.46	177.89	169.74	138.63
Other Operating Expenses	246.72	120.46	125.57	126.05	109.33
Operating Expenses	360.39	308.62	309.29	300.97	253.26
Operating Income	23.23	20.94	17.12	19.69	23.44
Interest Expense	-1.12	-0.97	-0.54	-0.72	-0.74
Interest & Investment Income	-	1.68	4.21	3.27	0.83
Other Non Operating Income (Expenses)	4.45	-0.07	-0.06	-0.08	-0.36
EBT Excluding Unusual Items	26.56	21.59	20.73	22.17	23.17
Pretax Income	26.56	21.59	20.73	22.17	23.17
Income Tax Expense	8.89	6.07	6.12	6.96	7.27
Net Income	17.66	15.52	14.61	15.21	15.89
Net Income to Common	17.66	15.52	14.61	15.21	15.89
Net Income Growth	13.82%	6.19%	-3.90%	-4.33%	45.47%
Shares Outstanding (Basic)	10	10	10	9	8
Shares Outstanding (Diluted)	10	10	10	9	9
Shares Change (YoY)	-0.10%	-	2.42%	10.93%	20.08%
EPS (Basic)	1.83	1.61	1.51	1.73	1.99
EPS (Diluted)	1.83	1.60	1.51	1.61	1.87
EPS Growth	14.37%	5.96%	-6.21%	-13.90%	21.43%
Free Cash Flow	53.96	0.1	-6.65	-8.48	1.08
Free Cash Flow Per Share	5.59	0.01	-0.69	-0.90	0.13
Dividend Per Share	1.000	0.800	0.800	0.750	0.750
Dividend Growth	25.00%	-	6.67%	-	50.00%
Gross Margin	54.85%	49.05%	48.51%	49.07%	42.24%
Operating Margin	3.32%	3.12%	2.54%	3.01%	3.58%
Profit Margin	2.53%	2.31%	2.17%	2.33%	2.43%
Free Cash Flow Margin	7.72%	0.01%	-0.99%	-1.30%	0.16%
EBITDA	30	25.4	21.3	23.23	26.95
EBITDA Margin	4.29%	3.78%	3.17%	3.55%	4.11%
D&A For EBITDA	6.77	4.46	4.18	3.54	3.51
EBIT	23.23	20.94	17.12	19.69	23.44
EBIT Margin	3.32%	3.12%	2.54%	3.01%	3.58%
Effective Tax Rate	33.49%	28.11%	29.51%	31.41%	31.39%
Revenue as Reported	703.79	673.6	677.04	656.76	655.83
Advertising Expenses	-	69.92	74.72	56.56	47.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.